457 related articles for article (PubMed ID: 31307984)
1. Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.
Ahmed MN; Porse A; Abdelsamad A; Sommer M; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307984
[TBL] [Abstract][Full Text] [Related]
2. Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.
Ahmed MN; Porse A; Sommer MOA; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760140
[TBL] [Abstract][Full Text] [Related]
3. Real-Time Monitoring of
Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
[TBL] [Abstract][Full Text] [Related]
4. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
Jensen PØ; Briales A; Brochmann RP; Wang H; Kragh KN; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Ciofu O
Pathog Dis; 2014 Apr; 70(3):440-3. PubMed ID: 24376174
[TBL] [Abstract][Full Text] [Related]
5. The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance.
Ahmed MN; Abdelsamad A; Wassermann T; Porse A; Becker J; Sommer MOA; Høiby N; Ciofu O
NPJ Biofilms Microbiomes; 2020 Jul; 6(1):28. PubMed ID: 32709907
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.
Macià MD; Pérez JL; Molin S; Oliver A
Antimicrob Agents Chemother; 2011 Nov; 55(11):5230-7. PubMed ID: 21859941
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a ciprofloxacin/amikacin combination against planktonic and biofilm cultures of susceptible and low-level resistant Pseudomonas aeruginosa.
Soares A; Alexandre K; Lamoureux F; Lemée L; Caron F; Pestel-Caron M; Etienne M
J Antimicrob Chemother; 2019 Nov; 74(11):3252-3259. PubMed ID: 31424553
[TBL] [Abstract][Full Text] [Related]
8. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.
De Kievit TR; Parkins MD; Gillis RJ; Srikumar R; Ceri H; Poole K; Iglewski BH; Storey DG
Antimicrob Agents Chemother; 2001 Jun; 45(6):1761-70. PubMed ID: 11353623
[TBL] [Abstract][Full Text] [Related]
9. Protective role of catalase in Pseudomonas aeruginosa biofilm resistance to hydrogen peroxide.
Elkins JG; Hassett DJ; Stewart PS; Schweizer HP; McDermott TR
Appl Environ Microbiol; 1999 Oct; 65(10):4594-600. PubMed ID: 10508094
[TBL] [Abstract][Full Text] [Related]
10. Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators.
Morero NR; Monti MR; Argaraña CE
Antimicrob Agents Chemother; 2011 Aug; 55(8):3668-76. PubMed ID: 21646492
[TBL] [Abstract][Full Text] [Related]
11. In vivo evolution of antimicrobial resistance in a biofilm model of Pseudomonas aeruginosa lung infection.
Higazy D; Pham AD; van Hasselt C; Høiby N; Jelsbak L; Moser C; Ciofu O
ISME J; 2024 Jan; 18(1):. PubMed ID: 38478426
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.
Maciá MD; Borrell N; Segura M; Gómez C; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2006 Mar; 50(3):975-83. PubMed ID: 16495260
[TBL] [Abstract][Full Text] [Related]
13. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms.
Brooun A; Liu S; Lewis K
Antimicrob Agents Chemother; 2000 Mar; 44(3):640-6. PubMed ID: 10681331
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms.
Gillis RJ; White KG; Choi KH; Wagner VE; Schweizer HP; Iglewski BH
Antimicrob Agents Chemother; 2005 Sep; 49(9):3858-67. PubMed ID: 16127063
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
Mulet X; Maciá MD; Mena A; Juan C; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2009 Apr; 53(4):1552-60. PubMed ID: 19188376
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
Tewes F; Bahamondez-Canas TF; Smyth HDC
AAPS PharmSciTech; 2019 May; 20(5):205. PubMed ID: 31144198
[TBL] [Abstract][Full Text] [Related]
17. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants.
Silva E; Monteiro R; Grainha T; Alves D; Pereira MO; Sousa AM
Front Cell Infect Microbiol; 2020; 10():441. PubMed ID: 32974221
[TBL] [Abstract][Full Text] [Related]
18. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
[TBL] [Abstract][Full Text] [Related]
20. Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa.
Su S; Panmanee W; Wilson JJ; Mahtani HK; Li Q; Vanderwielen BD; Makris TM; Rogers M; McDaniel C; Lipscomb JD; Irvin RT; Schurr MJ; Lancaster JR; Kovall RA; Hassett DJ
PLoS One; 2014; 9(3):e91813. PubMed ID: 24663218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
